FIELD: medicine, immunology. SUBSTANCE: invention proposes the composition for stimulation or enhancement of production of antibodies that are able to recognize ganglioside in person to whom composition is administrated. Composition has some amount of ganglioside (or its oligosaccharide moiety) conjugated with immunogenic protein and this amount is effective to stimulate or enhance production of antibodies in person. Composition has also adjuvant and pharmaceutically acceptable carrier. Invention proposes also method of use of composition for treatment or prophylaxis of cancer when gangliosides are located on surface or in stroma of cancer cells. EFFECT: enhanced effectiveness of composition. 34 cl, 14 tbl, 26 dwg
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION CONTAINING C-KIT-LIGAND AND HEMOPOIETIC FACTOR, METHOD OF ENHANCEMENT OF PERIPHERAL BLOOD STEM CELL LEVELS, ANTAGONIST OF C-KIT-LIGAND, ANTISENSE MOLECULE OF NUCLEIC ACID, METHOD OF ENHANCEMENT OF PERIPHERAL BLOOD CELL LEVELS EX-VIVO | 1993 |
|
RU2180850C2 |
LIPOSOMES RENDERING THYMUS-DEPENDENT ASSISTANCE TO "WEAK" ANTIGENS USED FOR PREPARING VACCINE | 1993 |
|
RU2107493C1 |
HAEMOPHILUS INFLUENZAE IMMUNOGENIC CONJUGATE POLYSACCHARIDE - PORIN OF MENINGOCOCCUS GROUP B (VARIANTS), METHOD FOR ITS PREPARING, PHARMACEUTICAL COMPOSITION AND METHOD FOR IMMUNE RESPONSE INDUCTION IN ANIMAL WITH REGARDS TO HAEMOPHILUS INFLUENZAE | 1998 |
|
RU2233172C2 |
METHOD FOR AUTOANTIGEN VACCINATION IN A HUMAN PATIENT | 2016 |
|
RU2734924C2 |
VACCINE COMPOSITION FOR CONTROLLING INFESTATION WITH ECTOPARASITES | 2011 |
|
RU2585226C2 |
COMPOSITIONS OF CARBOHYDRATE VACCINE FOR INDUCING IMMUNE RESPONSES AND USES THEREOF IN CANCER TREATMENT | 2014 |
|
RU2666141C2 |
METHOD OF CONVEYING BIOACTIVE AGENT TO ANIMAL FOR INITIATING IMMUNE RESPONSE | 1989 |
|
RU2127118C1 |
METHOD FOR DELIVERING BIOLOGICALLY ACTIVE COMPOUND ONTO MUCOSA-ASSOCIATED LYMPHORETICULAR ANIMAL TISSUE, METHOD FOR OBTAINING COMPOSITION AND COMPOSITION FOR DELIVERING BIOLOGICALLY ACTIVE COMPOUND | 1989 |
|
RU2250102C2 |
VIRUS-LIKE PARTICLES (VLP) VACCINE FOR PREVENTION OF COVID-19 FOR INTRANASAL USE | 2024 |
|
RU2828323C1 |
COMPOSITIONS OF PEPTIDE CONJUGATE AND METHODS FOR PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE | 2006 |
|
RU2406529C2 |
Authors
Dates
2001-09-27—Published
1994-01-21—Filed